Paper423919
Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
Stern RS and 4 others. N Engl J Med, 1979. Cited by 528 papers, by iCite.
Cite this record
ConductScience Library. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. Papers, record 423919. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/423919
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Basal Cell Carcinoma | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Methoxsalen | Major topic |
| Photochemotherapy | Major topic |
| Psoriasis | Major topic |
| Skin Neoplasms | Major topic |
| Administration, Oral | |
| Adult | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Prospective Studies | |
| Radiation, Ionizing | |
| Radiotherapy | |
| Risk | |
| Ultraviolet Therapy |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 528 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40177642 | Conceptual expansion of photomedicine for spatiotemporal treatment methods. | RSC Med Chem | 2025 | https://conductscience.org/library/papers/40177642 | PubMed |
| 37444683 | Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/37444683 | PubMed |
| 33491908 | Drug-induced photosensitivity: culprit drugs, potential mechanisms and clinical consequences. | J Dtsch Dermatol Ges | 2021 | https://conductscience.org/library/papers/33491908 | PubMed |
| 32110559 | Update on psoriasis: A review. | J Family Med Prim Care | 2020 | https://conductscience.org/library/papers/32110559 | PubMed |
| 32041351 | Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32041351 | PubMed |
| 30013973 | A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy. | Front Med (Lausanne) | 2018 | https://conductscience.org/library/papers/30013973 | PubMed |
| 27365149 | Absence of Basal Cell Carcinoma in Irradiated Childhood Cancer Survivors of Black Race: A Report from the St. Jude Lifetime Cohort Study. | Cancer Epidemiol Biomarkers Prev | 2016 | https://conductscience.org/library/papers/27365149 | PubMed |
| 24318782 | Fate of photosensitizing furanocoumarins in tolerant and sensitive insects. | J Chem Ecol | 1984 | https://conductscience.org/library/papers/24318782 | PubMed |
| 24263832 | Seasonal changes of furanocoumarin concentrations in leaves ofHeracleum lanatum. | J Chem Ecol | 1990 | https://conductscience.org/library/papers/24263832 | PubMed |
| 23812766 | Tumor suppressor in lung cancer 1 (TSLC1), a novel tumor suppressor gene, is implicated in the regulation of proliferation, invasion, cell cycle, apoptosis, and tumorigenicity in cutaneous squamous cell carcinoma. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23812766 | PubMed |
| 23616051 | [Phototherapy and carcinogenesis]. | Hautarzt | 2013 | https://conductscience.org/library/papers/23616051 | PubMed |
| 21616558 | Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin. | J Am Acad Dermatol | 2011 | https://conductscience.org/library/papers/21616558 | PubMed |
| 21263959 | Current treatment of psoriasis. | Can Fam Physician | 1987 | https://conductscience.org/library/papers/21263959 | PubMed |
| 19375190 | Incidence of nonmelanoma skin cancer in a cohort of patients with vitiligo. | J Am Acad Dermatol | 2009 | https://conductscience.org/library/papers/19375190 | PubMed |
| 18748772 | Dermatology-Epitomes of Progress: PUVA Carcinogenesis. | West J Med | 1981 | https://conductscience.org/library/papers/18748772 | PubMed |
| 17120167 | Anti-microbial photodynamic therapy: useful in the future? | Lasers Med Sci | 2007 | https://conductscience.org/library/papers/17120167 | PubMed |
| 9806110 | 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo. | Drugs | 1998 | https://conductscience.org/library/papers/9806110 | PubMed |
| 8741782 | Nonhormonal drugs and cancer. | Environ Health Perspect | 1995 | https://conductscience.org/library/papers/8741782 | PubMed |
| 8727021 | Contact dermatitis. Clinical perspectives and basic mechanisms. | Clin Rev Allergy Immunol | 1996 | https://conductscience.org/library/papers/8727021 | PubMed |
| 8713693 | Photosensitivity associated with antipsychotics, antidepressants and anxiolytics. | Drug Saf | 1996 | https://conductscience.org/library/papers/8713693 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/423919
GET https://conductscience.org/api/papers/v1/423919/cited_by?page=2